Inhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients With Hypoxemia
Inhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients With Hypoxemia
Recruiting · NCT07037836 · Registry updated 2026-08-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Inhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients With Hypoxemia | Chronic Disease, Disease Attributes, Hypoxemia, Hypoxia, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Respiratory, chronic obstructive pulmonary disease, lung disorder, obstructive lung disease, respiratory system disorder | Recruiting | Phase 2 | 2026-08-27 | NCT07037836 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bastiaan Driehuys | 9 |
| United Therapeutics | 18 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Duke Asthma Allergy and Airway Center | Durham | United States | 1 |